Utilization of peripheral blood stem cells in autotransplantation

Margaret Anne Kessinger

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Autologous blood-derived hematopoietic progenitors can be used like autologous bone marrow to restore hematopoiesis following marrow ablative therapy. Peripheral stem cell transplantation (PSCT) is preferable to autologous bone marrow transplantation (ABMT) if autologous marrow is not suitable for use as a graft product. Generally, this unsuitability results from marrow hypocellularity or metastatic disease. PSCT also has an advantage over ABMT in that it often restores marrow function more rapidly.

Original languageEnglish (US)
Pages (from-to)535-545
Number of pages11
JournalHematology/Oncology Clinics of North America
Volume7
Issue number3
StatePublished - Jan 1 1993

Fingerprint

Autologous Transplantation
Bone Marrow
Peripheral Blood Stem Cell Transplantation
Bone Marrow Transplantation
Hematopoiesis
Peripheral Blood Stem Cells
Transplants

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Utilization of peripheral blood stem cells in autotransplantation. / Kessinger, Margaret Anne.

In: Hematology/Oncology Clinics of North America, Vol. 7, No. 3, 01.01.1993, p. 535-545.

Research output: Contribution to journalArticle

@article{e4272170f67c48219376ef4aad7fd6a8,
title = "Utilization of peripheral blood stem cells in autotransplantation",
abstract = "Autologous blood-derived hematopoietic progenitors can be used like autologous bone marrow to restore hematopoiesis following marrow ablative therapy. Peripheral stem cell transplantation (PSCT) is preferable to autologous bone marrow transplantation (ABMT) if autologous marrow is not suitable for use as a graft product. Generally, this unsuitability results from marrow hypocellularity or metastatic disease. PSCT also has an advantage over ABMT in that it often restores marrow function more rapidly.",
author = "Kessinger, {Margaret Anne}",
year = "1993",
month = "1",
day = "1",
language = "English (US)",
volume = "7",
pages = "535--545",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Utilization of peripheral blood stem cells in autotransplantation

AU - Kessinger, Margaret Anne

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Autologous blood-derived hematopoietic progenitors can be used like autologous bone marrow to restore hematopoiesis following marrow ablative therapy. Peripheral stem cell transplantation (PSCT) is preferable to autologous bone marrow transplantation (ABMT) if autologous marrow is not suitable for use as a graft product. Generally, this unsuitability results from marrow hypocellularity or metastatic disease. PSCT also has an advantage over ABMT in that it often restores marrow function more rapidly.

AB - Autologous blood-derived hematopoietic progenitors can be used like autologous bone marrow to restore hematopoiesis following marrow ablative therapy. Peripheral stem cell transplantation (PSCT) is preferable to autologous bone marrow transplantation (ABMT) if autologous marrow is not suitable for use as a graft product. Generally, this unsuitability results from marrow hypocellularity or metastatic disease. PSCT also has an advantage over ABMT in that it often restores marrow function more rapidly.

UR - http://www.scopus.com/inward/record.url?scp=0027174230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027174230&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 535

EP - 545

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 3

ER -